FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025953409> ?p ?o ?g. }

• W2025953409 endingPage "308" @default.
• W2025953409 startingPage "301" @default.
• W2025953409 abstract "Gemcitabine has been increasingly prescribed for the treatment of gallbladder cancer. However, the response rate is low. The aim of this study is to determine whether icariin, a flavonoid isolated from Epimedi herba, could potentiate the antitumor activity of gemcitabine in gallbladder cancer. Human gallbladder carcinoma cell lines GBC-SD and SGC-996 were tested. Cell proliferation and apoptosis were analyzed using MTT assay and flow cytometry, respectively. The expression of apoptosis- and proliferation-related molecules was detected with Western blotting. Caspase-3 activity was analyzed using colorimetric assay, and NF-κB activity was measured with ELISA. A gallbladder cancer xenograft model was established in female BALB/c (nu/nu) mice. The mice were intraperitoneally administered gemcitabine (125 mg/kg) in combination with icariin (40 mg/kg) for 2 weeks. Icariin (40–160 μg/mL) dose-dependently suppressed cell proliferation and induced apoptosis in both GBC-SD and SGC-996 cells, with SGC-996 cells being less sensitive to the drug. Icariin (40 μg/mL) significantly enhanced the antitumor activity of gemcitabine (0.5 μmol/L) in both GBC-SD and SGC-996 cells. The mice bearing gallbladder cancer xenograft treated with gemcitabine in combination with icariin exhibited significantly smaller tumor size than the mice treated with either drug alone. In GBC-SD cells, icariin significantly inhibited both the constitutive and gemcitabine-induced NF-κB activity, enhanced caspase-3 activity, induced G0-G1 phase arrest, and suppressed the expression of Bcl-2, Bcl-xL and surviving proteins. Icariin, by suppressing NF-κB activity, exerts antitumor activity, and potentiates the antitumor activity of gemcitabine in gallbladder cancer. Combined administration of gemcitabine and icariin may offer a better therapeutic option for the patients with gallbladder cancer." @default.
• W2025953409 created "2016-06-24" @default.
• W2025953409 creator A5013660443 @default.
• W2025953409 creator A5062574247 @default.
• W2025953409 creator A5073663029 @default.
• W2025953409 creator A5074129701 @default.
• W2025953409 creator A5074281657 @default.
• W2025953409 date "2012-12-31" @default.
• W2025953409 modified "2023-10-03" @default.
• W2025953409 title "Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB" @default.
• W2025953409 cites W1971731246 @default.
• W2025953409 cites W1972583225 @default.
• W2025953409 cites W1975354698 @default.
• W2025953409 cites W1982294158 @default.
• W2025953409 cites W1995124041 @default.
• W2025953409 cites W2006478722 @default.
• W2025953409 cites W2015343262 @default.
• W2025953409 cites W2017982140 @default.
• W2025953409 cites W2018798914 @default.
• W2025953409 cites W2020576896 @default.
• W2025953409 cites W2040205108 @default.
• W2025953409 cites W2046728558 @default.
• W2025953409 cites W2049843152 @default.
• W2025953409 cites W2056427474 @default.
• W2025953409 cites W2067021997 @default.
• W2025953409 cites W2067241903 @default.
• W2025953409 cites W2077945404 @default.
• W2025953409 cites W2081220230 @default.
• W2025953409 cites W2083956139 @default.
• W2025953409 cites W2094193834 @default.
• W2025953409 cites W2097383206 @default.
• W2025953409 cites W2108015399 @default.
• W2025953409 cites W2119489119 @default.
• W2025953409 cites W2128624545 @default.
• W2025953409 cites W2148796201 @default.
• W2025953409 cites W2157719288 @default.
• W2025953409 cites W2164066037 @default.
• W2025953409 cites W2170619749 @default.
• W2025953409 cites W2313571237 @default.
• W2025953409 doi "https://doi.org/10.1038/aps.2012.162" @default.
• W2025953409 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4011607" @default.
• W2025953409 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23274410" @default.
• W2025953409 hasPublicationYear "2012" @default.
• W2025953409 type Work @default.
• W2025953409 sameAs 2025953409 @default.
• W2025953409 citedByCount "94" @default.
• W2025953409 countsByYear W20259534092013 @default.
• W2025953409 countsByYear W20259534092014 @default.
• W2025953409 countsByYear W20259534092015 @default.
• W2025953409 countsByYear W20259534092016 @default.
• W2025953409 countsByYear W20259534092017 @default.
• W2025953409 countsByYear W20259534092018 @default.
• W2025953409 countsByYear W20259534092019 @default.
• W2025953409 countsByYear W20259534092020 @default.
• W2025953409 countsByYear W20259534092021 @default.
• W2025953409 countsByYear W20259534092022 @default.
• W2025953409 countsByYear W20259534092023 @default.
• W2025953409 crossrefType "journal-article" @default.
• W2025953409 hasAuthorship W2025953409A5013660443 @default.
• W2025953409 hasAuthorship W2025953409A5062574247 @default.
• W2025953409 hasAuthorship W2025953409A5073663029 @default.
• W2025953409 hasAuthorship W2025953409A5074129701 @default.
• W2025953409 hasAuthorship W2025953409A5074281657 @default.
• W2025953409 hasBestOaLocation W20259534091 @default.
• W2025953409 hasConcept C121608353 @default.
• W2025953409 hasConcept C126322002 @default.
• W2025953409 hasConcept C142724271 @default.
• W2025953409 hasConcept C185592680 @default.
• W2025953409 hasConcept C190283241 @default.
• W2025953409 hasConcept C203014093 @default.
• W2025953409 hasConcept C204787440 @default.
• W2025953409 hasConcept C2776534502 @default.
• W2025953409 hasConcept C2777148285 @default.
• W2025953409 hasConcept C2780258809 @default.
• W2025953409 hasConcept C2780685212 @default.
• W2025953409 hasConcept C553184892 @default.
• W2025953409 hasConcept C55493867 @default.
• W2025953409 hasConcept C71924100 @default.
• W2025953409 hasConcept C98274493 @default.
• W2025953409 hasConceptScore W2025953409C121608353 @default.
• W2025953409 hasConceptScore W2025953409C126322002 @default.
• W2025953409 hasConceptScore W2025953409C142724271 @default.
• W2025953409 hasConceptScore W2025953409C185592680 @default.
• W2025953409 hasConceptScore W2025953409C190283241 @default.
• W2025953409 hasConceptScore W2025953409C203014093 @default.
• W2025953409 hasConceptScore W2025953409C204787440 @default.
• W2025953409 hasConceptScore W2025953409C2776534502 @default.
• W2025953409 hasConceptScore W2025953409C2777148285 @default.
• W2025953409 hasConceptScore W2025953409C2780258809 @default.
• W2025953409 hasConceptScore W2025953409C2780685212 @default.
• W2025953409 hasConceptScore W2025953409C553184892 @default.
• W2025953409 hasConceptScore W2025953409C55493867 @default.
• W2025953409 hasConceptScore W2025953409C71924100 @default.
• W2025953409 hasConceptScore W2025953409C98274493 @default.
• W2025953409 hasIssue "2" @default.
• W2025953409 hasLocation W20259534091 @default.
• W2025953409 hasLocation W20259534092 @default.
• W2025953409 hasLocation W20259534093 @default.

• next